Jonathan Jay Mazelsky - Aug 5, 2022 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
President & CEO, Director
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Jonathan Jay Mazelsky
Stock symbol
IDXX
Transactions as of
Aug 5, 2022
Transactions value $
-$72,993
Form type
4
Date filed
8/8/2022, 05:00 PM
Previous filing
May 23, 2022
Next filing
Nov 9, 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $0 +385 +0.75% $0.00 51.7K Aug 5, 2022 Direct F1
transaction IDXX Common Stock Tax liability -$73K -179 -0.35% $407.78 51.5K Aug 5, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Restricted Stock Unit Options Exercise -385 -3.71% 9.99K Aug 5, 2022 Common Stock 385 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 11 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on June 30, 2022.
F2 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning August 5, 2020.
F3 Not applicable.